There is no permanent cure for migraines, but the condition can be managed effectively enough that many people experience long stretches with few or no attacks. About 26 percent of people with chronic migraine transition back to episodic migraine (fewer and less severe attacks) within two years, and migraine prevalence generally drops after age 40. So while you can’t eliminate the underlying susceptibility, you can often reduce its impact dramatically.
Why a Permanent Cure Doesn’t Exist Yet
Migraine is rooted in how the nervous system processes signals. One key player is a signaling molecule called CGRP, which is found at high concentrations in the nerve clusters responsible for head and face pain. During an attack, CGRP levels rise in the blood and saliva, sensitizing those nerves so that even normal stimuli start registering as painful. This is why light, sound, or a gentle touch on the scalp can feel unbearable during a migraine.
The tendency toward this kind of nerve sensitization appears to be built into brain biology. Genetic research has identified rare mutations in genes that control nerve excitability, such as one affecting a potassium channel involved in pain modulation. But this particular mutation was found in only 1 out of 621 migraine patients studied, which illustrates a broader reality: migraine likely involves many overlapping genetic and environmental factors, not a single target that could be “switched off.” That complexity is the core reason a one-time cure remains out of reach.
What Remission Looks Like
The word doctors use more often than “cure” is “remission,” meaning a sustained reduction in attack frequency. A study tracking chronic migraine patients over two years found that about 1 in 4 remitted to episodic migraine, defined as dropping to 10 or fewer headache days per month. The strongest predictors of remission were having fewer headache days at baseline and the absence of allodynia (that skin-level pain sensitivity where normal touch hurts). People can also move in the other direction, shifting from episodic to chronic migraine and back again over time. It’s not a one-way street.
For many people, migraine naturally becomes less frequent and less intense with age. If you’re in your 20s or 30s dealing with frequent attacks, it’s worth knowing that the trajectory often improves, especially with consistent treatment.
Preventive Treatments That Reduce Attacks
The biggest shift in migraine treatment over the past decade has been the arrival of medications that specifically target the CGRP pathway. The American Headache Society now considers these a first-line option for migraine prevention. There are two main categories.
Monoclonal antibodies are injected or infused on a schedule. Erenumab, galcanezumab, and fremanezumab are self-injected once a month (fremanezumab can also be given every three months). Eptinezumab is an IV infusion given every three months at a clinic. These work by either blocking the CGRP receptor or binding to the CGRP molecule itself, preventing it from triggering nerve sensitization.
Oral preventives are also available. Atogepant is taken daily, while rimegepant is taken every other day. Both block the CGRP receptor directly.
For people with chronic migraine, meaning 15 or more headache days per month for at least three months with migraine features on at least 8 of those days, Botox injections are another option. The FDA-approved protocol involves 31 injections across seven head and neck muscles every 12 weeks.
Treating Attacks When They Happen
Even with good prevention, breakthrough attacks occur. Newer acute treatments called gepants can stop an attack already in progress. In long-term studies, the oral versions achieved pain freedom within two hours in roughly 23 to 25 percent of treated attacks, and meaningful pain relief in 65 to 68 percent. Those numbers might sound modest, but pain relief here means functional improvement, going from unable to work or think to getting through your day.
Gepants fill an important gap for people who can’t tolerate triptans (the older standard) or who have cardiovascular risk factors that make triptans a concern.
Drug-Free Devices
Neuromodulation devices offer a non-drug option for both prevention and acute treatment. One FDA-cleared wearable, Nerivio, uses remote electrical nerve stimulation worn on the upper arm. In a real-world study, nearly 78 percent of users reported pain relief, and about a third achieved complete pain freedom. Participants saw an average improvement of 4 fewer days per month of migraine-related disability. These devices work best as part of a broader treatment plan rather than a standalone solution, but they’re particularly appealing for people looking to reduce medication use.
What “Managing” Migraine Actually Means
In practice, effective migraine management usually involves layering strategies. A preventive medication or device reduces the baseline frequency of attacks. An acute treatment handles breakthroughs. And lifestyle factors, consistent sleep, regular meals, stress management, staying hydrated, help keep the nervous system less reactive overall. None of these individually constitutes a cure, but together they can transform the experience from dozens of lost days per month to a handful of manageable episodes per year.
The goal most headache specialists set with their patients isn’t zero attacks forever. It’s reaching a point where migraines no longer control your schedule, your work, or your relationships. For a growing number of people, that goal is achievable with today’s treatments.